Publication: First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon turkey study subgroup analysis
dc.contributor.author | Işıkdoğan, A. | |
dc.contributor.author | Türk, H. | |
dc.contributor.author | Bilir, C. | |
dc.contributor.author | Sendur, M. | |
dc.contributor.author | Karabulut, B. | |
dc.contributor.author | Artaç, M. | |
dc.contributor.author | Cicin, I. | |
dc.contributor.author | Geredeli, C. | |
dc.contributor.author | Alacacıoğlu, A. | |
dc.contributor.author | Kefeli, U. | |
dc.contributor.author | Harputluoğlu, H. | |
dc.contributor.author | Bozkurt, O. | |
dc.contributor.author | Çubukcu, E. | |
dc.contributor.author | Tural, D. | |
dc.contributor.author | Sakin, A. | |
dc.contributor.author | Çil, T. | |
dc.contributor.author | Dane, F. | |
dc.contributor.author | Çevik, D. | |
dc.contributor.author | Arslan, C. | |
dc.contributor.author | Karadurmuş, N. | |
dc.contributor.author | Gümüş, M. | |
dc.contributor.author | Yalçın, S. | |
dc.contributor.buuauthor | ÇUBUKÇU, ERDEM | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.researcherid | ETP-1691-2022 | |
dc.date.accessioned | 2024-12-04T05:12:26Z | |
dc.date.available | 2024-12-04T05:12:26Z | |
dc.date.issued | 2022-06-01 | |
dc.description | Bu çalışma, 19 Haziran-02 Temmuz, 2022 tarihlerinde Barcelona[İspanya]’da düzenlenen ESMO 24. World Congress on Gastrointestinal Cancer Kongresi‘nde bildiri olarak sunulmuştur. | |
dc.description.sponsorship | European Soc Med Oncol | |
dc.identifier.doi | 10.1016/j.annonc.2022.04.180 | |
dc.identifier.eissn | 1569-8041 | |
dc.identifier.endpage | S281 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.startpage | S281 | |
dc.identifier.uri | https://doi.org/10.1016/j.annonc.2022.04.180 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0923753422008705?via%3Dihub | |
dc.identifier.uri | https://hdl.handle.net/11452/48838 | |
dc.identifier.volume | 33 | |
dc.indexed.wos | WOS.SCI | |
dc.indexed.wos | WOS.ISTP | |
dc.language.iso | en | |
dc.publisher | Elsevier | |
dc.relation.journal | Annals of Oncology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Oncology | |
dc.title | First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon turkey study subgroup analysis | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi | |
relation.isAuthorOfPublication | f971677f-09c5-4463-bf01-3c6341fbe5f7 | |
relation.isAuthorOfPublication.latestForDiscovery | f971677f-09c5-4463-bf01-3c6341fbe5f7 |
Files
Original bundle
1 - 1 of 1